Table 1 IAR characteristics (n = 286)
| Group 1 (n = 139) | Group 2 (n = 48) | Group 3 (n = 93) | p-value | |
|---|---|---|---|---|
| Gender (m/f) | 59/80 | 19/29 | 40/53 | 0.9218 |
| Age at 1st counseling, median range |
47 years (27–72 yr.) |
44 years (27–63 yr.) |
49 years (20–73 yr.) | 0.1616 |
| Distance to screening visit | Median 190 km | Median 190 km | Median 300 km | 1 + 2: 0.3816 |
| < 50 km | 6 | 0 | 2 | 1 + 3:< 0.0001 |
| 50–100 km | 18 | 4 | 2 | 2 + 3: 0.0055 |
| 100–200 km | 56 | 21 | 20 | |
| >200Km | 59 | 23 | 69 | |
| FPC | 127 | 45 | 84 | 0.7882 |
| Syndromic PC | ||||
| - p16 | 0 | 0 | 0 | |
| - BRCA1/2 | 9 | 1 | 8 | |
| - PALB2 | 3 | 2 | 1 | |
| - Other | 0 | 0 | 0 | |
| Number of high risk IAR | 74 | 18 | 31 | 1 + 2:0.0671 |
| Number of medium risk IAR | 65 | 30 | 62 |
1 + 3:0.0031 2 + 3:0.7096 |
| Underwent surveillance with: | none | |||
| MRI + EUS | 139 | 41 | ||
| MRI only | 0 | 7 | ||
| EUS only | 0 | 0 | ||
| Number of screening visits, median (range) | 4 (2–12) | 2 (1–8) | none | |
| Mean value | 5.0 | 2.6 | ||